Wockhardt Ltd has acquired a German pharma company called
Esparma Gmbh for dollars11 million.
acquisition does not include the company''s manufacturing
facility but covers the businesses, sales and marketing
organisation and the name of the company, said Habil
Khorakiwala, chairman, Wockhardt.
will continue manufacturing at Esparma facilities, which
have been sold to another buyer.
toll manufacturing agreement is for a period of two
years, after which Wockhardt will shift manufacturing
to its other existing facilities in the UK and India,
has set up a company called Wockhardt Germany, GmbH
to facilitate the acquisition. The company will have
70 employees, most of them in sales, marketing and regulatory